A Pharmacokinetic Study of Intravenous NTM-001 in Healthy Chinese Subjects

Clinical trial NCT05382546 · COMPLETED

Trial details

NCT number: NCT05382546
Sponsor: Nuance Pharma (shanghai) Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2022-05-23
Primary completion: 2022-07-05
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.